ATE400602T1 - Verfahren zur herstellung von hydrogelen aus thiosulfonat-zusammensetzungen und ihre verwendungen - Google Patents

Verfahren zur herstellung von hydrogelen aus thiosulfonat-zusammensetzungen und ihre verwendungen

Info

Publication number
ATE400602T1
ATE400602T1 AT03800398T AT03800398T ATE400602T1 AT E400602 T1 ATE400602 T1 AT E400602T1 AT 03800398 T AT03800398 T AT 03800398T AT 03800398 T AT03800398 T AT 03800398T AT E400602 T1 ATE400602 T1 AT E400602T1
Authority
AT
Austria
Prior art keywords
thiosulfonate
compositions
hydrogels
forming
hydrogel
Prior art date
Application number
AT03800398T
Other languages
English (en)
Inventor
Michael Bentley
Zhihao Fang
Original Assignee
Nektar Therapeutics Al Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nektar Therapeutics Al Corp filed Critical Nektar Therapeutics Al Corp
Application granted granted Critical
Publication of ATE400602T1 publication Critical patent/ATE400602T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32—Polymers modified by chemical after-treatment
    • C08G65/329—Polymers modified by chemical after-treatment with organic compounds
    • C08G65/334—Polymers modified by chemical after-treatment with organic compounds containing sulfur
    • C08G65/3342—Polymers modified by chemical after-treatment with organic compounds containing sulfur having sulfur bound to carbon and hydrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0031—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/046—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32—Polymers modified by chemical after-treatment
    • C08G65/329—Polymers modified by chemical after-treatment with organic compounds
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/24—Crosslinking, e.g. vulcanising, of macromolecules
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2300/00—Characterised by the use of unspecified polymers
    • C08J2300/14—Water soluble or water swellable polymers, e.g. aqueous gels
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2381/00—Characterised by the use of macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing sulfur with or without nitrogen, oxygen, or carbon only; Polysulfones; Derivatives of such polymers
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L2203/00—Applications
    • C08L2203/02—Applications for biomedical use

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Materials Engineering (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Polyethers (AREA)
  • Colloid Chemistry (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
AT03800398T 2002-12-31 2003-12-31 Verfahren zur herstellung von hydrogelen aus thiosulfonat-zusammensetzungen und ihre verwendungen ATE400602T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US43725202P 2002-12-31 2002-12-31

Publications (1)

Publication Number Publication Date
ATE400602T1 true ATE400602T1 (de) 2008-07-15

Family

ID=32713157

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03800398T ATE400602T1 (de) 2002-12-31 2003-12-31 Verfahren zur herstellung von hydrogelen aus thiosulfonat-zusammensetzungen und ihre verwendungen

Country Status (6)

Country Link
US (5) US7312301B2 (de)
EP (1) EP1578843B1 (de)
AT (1) ATE400602T1 (de)
AU (1) AU2003300140A1 (de)
DE (1) DE60322111D1 (de)
WO (1) WO2004060967A1 (de)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004060967A1 (en) 2002-12-31 2004-07-22 Nektar Therapeutics Al, Corporation Methods for the formation of hydrogels using thiosulfonate compositions and uses thereof
EP1596887B1 (de) * 2003-02-26 2022-03-23 Nektar Therapeutics Polymer-factor viii-konjugate
AU2004229478B2 (en) * 2003-04-10 2009-12-24 3M Innovative Properties Company Delivery of immune response modifier compounds
EP1617872A4 (de) * 2003-04-10 2011-09-07 3M Innovative Properties Co Verfahren und zusammensetzungen zur verbesserung der immunantwort
EP1725262B1 (de) 2004-03-15 2021-05-26 Nektar Therapeutics Polymerische Zusammensetzungen und Konjugate von HIV-Entry-Inhibitoren
WO2006034128A2 (en) * 2004-09-17 2006-03-30 Angiotech Biomaterials Corporation Multifunctional compounds for forming crosslinked biomaterials and methods of preparation and use
US20070060658A1 (en) * 2005-08-31 2007-03-15 Diaz David D Stabilization of organogels and hydrogels by azide-alkyne [3+2] cycloaddition
WO2007075534A2 (en) 2005-12-16 2007-07-05 Nektar Therapeutics Al, Corporation Polymer conjugates of glp-1
US7671067B2 (en) 2006-02-09 2010-03-02 Enzon Pharmaceuticals, Inc. Treatment of non-hodgkin's lymphomas with multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamtothecin
US7462627B2 (en) 2006-02-09 2008-12-09 Enzon Pharmaceuticals, Inc. Multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin for treatment of breast, colorectal, pancreatic, ovarian and lung cancers
US8377091B2 (en) 2006-06-15 2013-02-19 Microvention, Inc. Embolization device constructed from expansile polymer
EP1891941A1 (de) * 2006-08-11 2008-02-27 OctoPlus Technologies B.V. Wässrige Gele enthaltend Mikrokügelchen
MX2009008549A (es) 2007-02-09 2009-08-18 Enzon Pharmaceuticals Inc Tratamiento de canceres resistentes o refractarios con conjugados polimericos de brazos multiples de 7-etil-10-hidroxicamptotecina.
US20080287633A1 (en) * 2007-05-18 2008-11-20 Drumheller Paul D Hydrogel Materials
US8067028B2 (en) * 2007-08-13 2011-11-29 Confluent Surgical Inc. Drug delivery device
CN101903051B (zh) 2007-12-21 2013-07-31 微温森公司 用于生物医药用途的水凝胶细丝
US20100112014A1 (en) * 2008-04-11 2010-05-06 Gilbert Ryan J Novel hydrogel compositions and methods of using
US10799593B2 (en) 2008-06-09 2020-10-13 Northwestern University Nanodiamond particle complexes
US20100040672A1 (en) * 2008-06-09 2010-02-18 Northwestern University Delivery of therapeutics
KR101671537B1 (ko) * 2008-08-11 2016-11-01 넥타르 테라퓨틱스 다분지형 중합체 알카노에이트 컨쥬게이트
US8443146B2 (en) * 2008-09-18 2013-05-14 International Business Machines Corporation Techniques for cache injection in a processor system responsive to a specific instruction sequence
US8429349B2 (en) * 2008-09-18 2013-04-23 International Business Machines Corporation Techniques for cache injection in a processor system with replacement policy position modification
US10639396B2 (en) 2015-06-11 2020-05-05 Microvention, Inc. Polymers
BRPI1014645B1 (pt) 2009-04-30 2020-07-07 Technip France método e sistema para compartilhar linhas de amarração
CN102791183B (zh) 2009-10-26 2015-07-08 微排放器公司 由可膨胀的聚合物构成的栓塞装置
WO2011065916A1 (en) * 2009-11-24 2011-06-03 Agency For Science, Technology And Research Crosslinking branched molecule through thiol-disulfide exchange to form hydrogel
US8524215B2 (en) * 2010-08-02 2013-09-03 Janssen Biotech, Inc. Absorbable PEG-based hydrogels
US10894087B2 (en) 2010-12-22 2021-01-19 Nektar Therapeutics Multi-arm polymeric prodrug conjugates of cabazitaxel-based compounds
US20130331443A1 (en) 2010-12-22 2013-12-12 Nektar Therapeutics Multi-arm polymeric prodrug conjugates of taxane-based compounds
WO2012145431A2 (en) 2011-04-18 2012-10-26 Microvention, Inc. Embolic devices
SG11201400444VA (en) * 2011-09-07 2014-04-28 Prolynx Llc Hydrogels with biodegradable crosslinking
WO2013158781A1 (en) 2012-04-18 2013-10-24 Microvention, Inc. Embolic devices
EP2861257B1 (de) 2012-06-14 2021-12-08 Microvention, Inc. Polymere behandlungszusammensetzungen
JP6139664B2 (ja) 2012-09-12 2017-05-31 ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. ステントおよびステントの作製方法
US20150267196A1 (en) * 2012-10-12 2015-09-24 Case Western Reserve University Biodegradable hydrogel for polynucleotide delivery
BR112015008245B1 (pt) 2012-10-15 2022-09-27 Microvention, Inc Composições poliméricas de tratamento
WO2015020676A1 (en) 2013-08-08 2015-02-12 Boston Scientific Scimed, Inc. Dissolvable or degradable adhesive polymer to prevent stent migration
US10173375B2 (en) 2014-03-05 2019-01-08 Bacterin International, Inc. Shaped fiber-based products and method of manufacture thereof
WO2015153996A1 (en) 2014-04-03 2015-10-08 Micro Vention, Inc. Embolic devices
JP6599361B2 (ja) 2014-04-29 2019-10-30 マイクロベンション インコーポレイテッド 活性剤を含むポリマー
US10092663B2 (en) 2014-04-29 2018-10-09 Terumo Corporation Polymers
WO2016172143A1 (en) * 2015-04-21 2016-10-27 Tufts University Fabrication of macroporous monodisperse hydrogel microspheres
US10821004B2 (en) * 2015-06-30 2020-11-03 Bacterin Interational, Inc. Expandable bone grafts and methods of manufacture thereof
US10368874B2 (en) 2016-08-26 2019-08-06 Microvention, Inc. Embolic compositions
CN107602432B (zh) * 2017-10-01 2019-06-07 刘云晖 一种可溶性水凝胶用交联剂及其制备方法和应用
CN111200976B (zh) 2017-10-09 2023-07-07 微仙美国有限公司 放射性液体栓塞
MX2021011997A (es) 2019-04-05 2021-11-04 Prolynx Llc Enlazadores de conjugacion mejorados.
CN114072132B (zh) * 2019-07-09 2024-11-15 赛拉尔研究有限公司 仿生组织黏附性水凝胶贴片及其用途
CN111388748B (zh) * 2020-03-03 2021-08-06 东华大学 一种抗菌止血多功能复合水凝胶敷料及其制备方法
US12576399B2 (en) 2021-01-08 2026-03-17 Cellanome, Inc. Methods for imaging and analyzing a cell in a compartment of a fluidic device
US12576400B2 (en) 2021-01-08 2026-03-17 Cellanome, Inc. Methods for incubating and analyzing a cell in a compartment of a fluidic device
WO2025128916A1 (en) * 2023-12-13 2025-06-19 Cellanome, Inc. Devices and methods for analyzing biological samples

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE598976A (de) * 1960-01-11
DE1223156B (de) * 1961-05-27 1966-08-18 Hoechst Ag Verfahren zur Herstellung von hoehermolekularen Polykondensaten
CS159361B1 (de) * 1970-09-08 1975-01-31
IE49097B1 (en) * 1978-11-10 1985-07-24 Ic Gas Int Ltd Thermal energy storage material
GB2047093B (en) * 1979-03-21 1983-12-07 Graham N B Controlled release compositions
JPS60114584A (ja) * 1983-11-25 1985-06-21 Otsuka Chem Co Ltd チオスルホナ−ト誘導体の製造法
JP2664153B2 (ja) * 1987-06-05 1997-10-15 富士写真フイルム株式会社 ハロゲン化銀カラー写真感光材料およびその現像処理方法
US4983579A (en) * 1988-11-18 1991-01-08 International Flavors & Fragrances Inc. Cyano-substituted sulfur containing compounds, compositions containing same, processes for preparing same and organoleptic uses thereof
DE4014537A1 (de) * 1990-05-07 1991-11-14 Goldschmidt Ag Th Verfahren zur herstellung von hochelastischen, polyurethangruppen aufweisenden schaumstoffen mit verminderter stauchhaerte
US5393798A (en) * 1992-06-05 1995-02-28 Spenco Medical Corporation Hydrogel material and method of preparation
FI950062A7 (fi) 1992-07-06 1995-01-05 Biomira Inc Proteiinien foroaktivaatio konjugaatiotarkoituksia varten
US5672662A (en) * 1995-07-07 1997-09-30 Shearwater Polymers, Inc. Poly(ethylene glycol) and related polymers monosubstituted with propionic or butanoic acids and functional derivatives thereof for biotechnical applications
CA2323048C (en) 1998-03-12 2006-10-10 Shearwater Polymers, Inc. Poly(ethylene glycol) derivatives with proximal reactive groups
CA2331783C (en) * 1998-07-02 2009-12-29 Genencor International, Inc. Chemically modified proteins with a carbohydrate moiety
US6131274A (en) * 1999-07-01 2000-10-17 3Com Corporation Apparatus and method for guiding a circuit board into an electronic chassis
MXPA02003540A (es) 1999-10-08 2003-09-12 Nektar Therapeutics Al Corp Derivados de poli(etilenglicol) heterobifuncionales y los metodos para su preparacion.
MY133977A (en) * 2000-06-16 2007-11-30 Nippon Catalytic Chem Ind Crosslinked polymers containing tertiary amine and/or quaternary ammonium salt structures, processes for making and uses thereof
JP2002049123A (ja) * 2000-08-04 2002-02-15 Fuji Photo Film Co Ltd 熱現像感光材料および画像形成方法
WO2002026170A2 (en) * 2000-09-26 2002-04-04 Neurortho Implants Design, Llc Inter-vertebral disc prosthesis for lumbar rachis through posterior surgery thereof
TW593427B (en) * 2000-12-18 2004-06-21 Nektar Therapeutics Al Corp Synthesis of high molecular weight non-peptidic polymer derivatives
US7053150B2 (en) * 2000-12-18 2006-05-30 Nektar Therapeutics Al, Corporation Segmented polymers and their conjugates
WO2004060967A1 (en) 2002-12-31 2004-07-22 Nektar Therapeutics Al, Corporation Methods for the formation of hydrogels using thiosulfonate compositions and uses thereof

Also Published As

Publication number Publication date
US20120088927A1 (en) 2012-04-12
US20080033105A1 (en) 2008-02-07
US20050143484A1 (en) 2005-06-30
US7598338B2 (en) 2009-10-06
AU2003300140A1 (en) 2004-07-29
US8450390B2 (en) 2013-05-28
US20100004424A1 (en) 2010-01-07
DE60322111D1 (de) 2008-08-21
US8247598B2 (en) 2012-08-21
US20120289609A1 (en) 2012-11-15
US7312301B2 (en) 2007-12-25
US8097695B2 (en) 2012-01-17
EP1578843B1 (de) 2008-07-09
EP1578843A1 (de) 2005-09-28
WO2004060967A1 (en) 2004-07-22

Similar Documents

Publication Publication Date Title
DE60322111D1 (de) Verfahren zur herstellung von hydrogelen aus thiosulfonat-zusammensetzungen und ihre verwendungen
DE50309432D1 (de) Verfahren zur herstellung von wässrigen dispersionen
EA200600440A1 (ru) 4-((феноксиалкил)тио)еноксиуксусные кислоты и их аналоги
DE60222741D1 (de) Verfahren zur herstellung von beschichteter polymerfolie
ATE427342T1 (de) Modifizierte pigmente, ein verfahren zur herstellung von modifizierten pigmenten und sie enthaltende tintenzusammensetzungen
DE602005024277D1 (de) Verfahren und vorrichtung zur ermöglichung von entlient-einrichtung
AR038563A1 (es) Composicion de ziprasidona y controles sinteticos
ATE547101T1 (de) Verfahren zur verwendung von diketopiperazinen und zusammensetzungen, die diese enthalten
ATE480643T1 (de) Homogener nachweis von analyten
ECSP045255A (es) Cumarinas utiles como biomarcadores
BRPI0518334A2 (pt) composiÇço de revestimento, mÉtodo de revestimento, revestimento, e, mÉtodo para preparar uma composiÇço de revestimento
DE60308159D1 (de) Verfahren zur herstellung von polymeren microsphären
ATE366923T1 (de) Vorrichtung zur referenzierung von fluoreszenzsignalen
DE60233686D1 (de) Verfahren zur Herstellung von polymeren phosphorhaltigen Zusammensetzungen
PT1560812E (pt) Compostos de aminociclohexil eter e suas utilizacoes
DE69821376D1 (de) Verfahren zur proteinrückfaltung durch verwendung zwitterionischer wirkstoffe von niedrigem molekulargewicht
ATE309283T1 (de) Wässrige dispersion und ihre verwendung zur herstellung von thermisch und mit aktinischer strahlung härtbaren beschichtungsstoffen, klebstoffen und dichtmassen
ATE460451T1 (de) Verfahren zur herstellung von funktionalisierten polymeren aus polymeralkoholen
EA200500074A1 (ru) Пленочное покрытие для таблеток и каплет
NO20072880L (no) Injiserbar vetrinaerblanding
BR0315557A (pt) Substrato, uso de um polìmero hiper-ramificado que tem grupos uretano e/ou grupos uréia, e, processo para modificar as propriedades da superfìcie de substratos
DE60304583D1 (de) Verfahren zur herstellung von pastenextrudierten sulfonamidzusammensetzungen
ATE326437T1 (de) Beschichtungszusammensetzung, insbesondere für glasoberflächen, und verfahren zu deren herstellung und verwendung
DE60334875D1 (de) Verfahren zur Herstellung von Fluorpolymerzusammensetzungen welche anorganische Nanopartikel enthalten
WO2003057792A3 (en) Composition containing a polymerizable reducing agent, kit, and method

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties